Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
09/01/1994 | WO1994018835A1 Treatment of androgen-associated baldness using antisense oligomers |
09/01/1994 | WO1994016069A3 Ras associated gap proteins |
09/01/1994 | WO1994012638A3 Interleukin-3 (il-3) multiple mutation polypeptides |
09/01/1994 | CA2156919A1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
09/01/1994 | CA2156850A1 Harp family growing factors, preparation methods and uses thereof |
09/01/1994 | CA2156826A1 Combination cisplatin/tamoxifen therapy for human cancers |
09/01/1994 | CA2155338A1 Retroviral protease inhibiting compounds |
09/01/1994 | CA2152925A1 Azacyclic compounds compositions containing them and their use as tachykinin antagonists |
09/01/1994 | CA2118314A1 Methods for treating arteriosclerosis |
08/31/1994 | EP0613006A1 Antibodies to cachectin and immunoassays |
08/31/1994 | EP0612743A1 Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels |
08/31/1994 | EP0612741A1 Cyclic derivatives, medicaments containing them and process for their preparation |
08/31/1994 | EP0612733A1 Use of Phthaloylhydrazide Derivatives as Anti-Hypoxic and defensive Agents |
08/31/1994 | EP0612723A1 Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them |
08/31/1994 | EP0612531A1 Therapeutic agent for digestive tract diseases |
08/31/1994 | EP0612524A1 Angiotensin II antagonists for the treatment of viral diseases |
08/31/1994 | EP0612520A2 PH-triggered osmotic bursting delivery devices |
08/31/1994 | EP0612348A1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
08/31/1994 | EP0612324A1 Phosphonopeptides with collagenase inhibiting activity |
08/31/1994 | EP0612321A1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
08/31/1994 | EP0612249A1 Methods of inhibiting restenosis |
08/31/1994 | EP0612246A1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
08/31/1994 | EP0612244A1 Endothelin receptor antagonists |
08/31/1994 | EP0612211A1 Alteration of rate and character of hair growth |
08/31/1994 | EP0549645B1 New 17- -oestradiol derivatives, a method of preparing them, and drugs containing them |
08/31/1994 | EP0496796B1 Method and compositions for inhibition of disorders associated with oxidative damage |
08/31/1994 | EP0474733B1 Antihyperlipidemic and antiatherosclerotic urea compounds |
08/31/1994 | EP0259475B1 Recombinant human endothelial cell growth factor |
08/31/1994 | CN1091469A PTP 1D, a novel protein tyrosine phosphatase |
08/31/1994 | CN1091429A 内酰胺衍生物 Lactam derivatives |
08/31/1994 | CN1091285A Fatty acid treatment |
08/31/1994 | CN1025786C Carbamoyl derivatives |
08/30/1994 | US5342960 Inhibit synthesis and release of histamine |
08/30/1994 | US5342959 Process for preparing chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compounds |
08/30/1994 | US5342948 Antiandrogens; ozonation, amination, reduction of androstane derivative with acyl(urea or thiourea) |
08/30/1994 | US5342831 Wound healing, bed sores |
08/30/1994 | US5342627 Controlled release device |
08/30/1994 | US5342615 Method for treating arthritis or inflammation with Il-1α or derivatives thereof |
08/30/1994 | CA1331757C 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
08/28/1994 | CA2116286A1 N-heteroaryl-n'-phenylurea derivatives, their production and use |
08/25/1994 | CA2115377A1 Therapeutic agent for digestive tract diseases |
08/24/1994 | EP0611767A1 Heterocyclic substituted phenyl-cyclohexan carboxylic acid derivatives as angiotensin II antagonists |
08/24/1994 | EP0611765A1 2-(Imidazol-1-yl)-3-heteroarylpropylidene-aminoxyalkanoic acid derivatives |
08/24/1994 | EP0611756A2 Alcohol or aldehyde derivatives as cathepsin L inhibitor and bone resorption inhibitor |
08/24/1994 | EP0611660A2 Condensed 5-membered heterocycles, process for their preparation and medicines containing these compounds |
08/24/1994 | EP0611573A2 Bioactive conjugates of cellulose with amino compounds |
08/24/1994 | EP0611570A1 Use of chromic tripicolinate in the treatment of obese diabetic patients |
08/24/1994 | EP0611375A1 Peptides inhibiting il-1 beta release |
08/24/1994 | CN1091134A Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
08/24/1994 | CN1091132A Novel isoxazolines as antiinflammatory agents |
08/24/1994 | CN1091129A Excitatory amino acid receptor antagonists |
08/23/1994 | WO1994019371A1 Novel peptide having elastase inhibitor activity and process for producing the same |
08/23/1994 | US5340833 Urokinase inhibitors |
08/23/1994 | US5340822 Substance P, neurokinin antagonists |
08/23/1994 | US5340821 Spirooxathiolane-quinuclidien derivative |
08/23/1994 | US5340815 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
08/23/1994 | US5340813 Substituted aminoalkyl xanthine compounds |
08/23/1994 | US5340807 Tricyclic compounds and intermediates thereof |
08/23/1994 | US5340574 Stabilized non-glycosylated recombinant human IL2 in reduced form compositions |
08/23/1994 | US5340565 Tumor or cancer cell killing therapy and agents useful therefor |
08/23/1994 | CA2116068A1 Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
08/23/1994 | CA1331610C Antihypertensive 3-piperidinyl-indazole derivatives |
08/23/1994 | CA1331609C Antipsychotic 3-piperazinylbenzazole derivatives |
08/23/1994 | CA1331606C Calcium independent camp phosphodiesterase inhibitor antidepressant |
08/23/1994 | CA1331568C Pharmaceutical composition containing dihydropyridine-dianhydrohexitol and nitro derivative |
08/23/1994 | CA1331564C Redox systems for brain-targeted drug delivery |
08/21/1994 | CA2115967A1 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical, as inhibitors of the cellular na+/h+exchange or as a diagnostic, and pharmaceutical containing them |
08/20/1994 | CA2115913A1 Alcohol or aldehyde derivatives and their use |
08/18/1994 | WO1994018319A1 Novel polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and use thereof |
08/18/1994 | WO1994018308A1 Novel receptor-type phosphotyrosine phosphatase-beta |
08/18/1994 | WO1994018215A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
08/18/1994 | WO1994018200A1 Novel inhibitors of adenosine monophosphate deaminase |
08/18/1994 | WO1994018194A1 Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as intiinflammatory agents |
08/18/1994 | WO1994018188A1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl[b]pyran-2-ones useful to treat retroviral infections |
08/18/1994 | WO1994018170A1 Use of phenyl heteroaryl ureas as 5ht2c receptor antagonists and urea compounds |
08/18/1994 | WO1994018169A1 Benzo-fused lactams promote release of growth hormone |
08/18/1994 | WO1994018168A1 Indole derivatives as 5-alpha-reductase inhibitors |
08/18/1994 | WO1994017816A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
08/18/1994 | WO1994017811A1 Wound-healing compositions containing iodine and a non-reducing sugar |
08/18/1994 | WO1994017790A1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
08/18/1994 | WO1994017778A1 Method of enhancing hair growth and hair revitalizing compositions comprising lutzomyia protein |
08/18/1994 | WO1994010203A3 Op-3-induced morphogenesis |
08/18/1994 | WO1994006454A3 Inhibitiion of retrovirus infection |
08/18/1994 | CA2155866A1 Method of enhancing hair growth and hair revitalizing compositions comprising lutzomyia protein |
08/18/1994 | CA2155848A1 Wound-healing ccompositions containing iodine and a non-reducing sugar |
08/18/1994 | CA2155554A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
08/18/1994 | CA2155545A1 Novel receptor-type phosphotyrosine phosphatase-beta |
08/18/1994 | CA2154687A1 Benzo-fused lactams promote release of growth hormone |
08/18/1994 | CA2154681A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
08/18/1994 | CA2153237A1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl[b]pyran-2-ones useful to treat retroviral infections |
08/18/1994 | CA2153162A1 New polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and uses thereof |
08/17/1994 | EP0610743A1 Novel aminomethylene-peptides as immunosuppressants |
08/17/1994 | EP0610698A2 Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes |
08/17/1994 | EP0610697A1 Imidazole substituted phenylaceticacidprolinzamide derivatives |
08/17/1994 | EP0610655A1 Medicament containing dexpanthenol for topical application |
08/17/1994 | EP0610475A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
08/17/1994 | EP0610427A1 TGF-$g(b) TYPE RECEPTOR cDNAS AND USES THEREFOR |
08/17/1994 | EP0610420A1 Cell cycle controlling compositions and methods of using same |
08/17/1994 | EP0610368A1 Treatment of acne or of pseudofolliculitis barbae |
08/17/1994 | EP0610334A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII b?III a? RECEPTOR. |